Replies to post #147826 on Enzolytics Inc (ENZC)

[foxi]

I found this in Supplemental Information - SHARE ISSUANCE HISTORY AND DILUTION from 03/16/22:

This information lists each original common stock issuance of Enzolytics, Inc. (“ENZC” or the “Company”), and its predecessors, from April 6, 2012 through October 15, 2020. There have been no original issuance of ENZC shares since October 15, 2020. ENZC is a Delaware Corporation that filed a reorganization merger under 251g of the Delaware Corporate Statute on November 16, 2020. All outstanding debt of the Company flowed to its subsidiary, now known as Robustomed, Inc. This means there are no outstanding convertible debt pieces of ENZC common equity, and that has been the case since November 30, 2020. This has been disclosed in all filings made on OTC (both annual and quarterly) since that date.

I'm not sure how it gels with them reporting derivative liabilities as late as September 2021. They defined "derivative liabilities" as notes convertible to common stock on page 28 of this old filing.

Also in 2019 ENZC did a debt conversion into 941,078 shares of Series C Preferred stock, which isn't "common equity", but afaik is convertible back into such. Those shares remained in the totals for 2020 and presumably forward. (I haven't fully traced them yet.)